Adamis Pharmaceuticals Corporation Profile Avatar - Palmy Investing

Adamis Pharmaceuticals Corporation

Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candid…

Drug Manufacturers - Specialty & Generic
US, San Diego [HQ]

Risk Factors

By Management
Not Available

    No Risk Factor available yet. You can request "Risk Factors" through an email.

End of ADMP's Analysis
CIK: 887247 CUSIP: 00547W208 ISIN: US00547W2089 LEI: - UEI: -
Secondary Listings
ADMP has no secondary listings inside our databases.